More than 75% of LeqembiÂ-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEAD

gurufocus.com - 2026-07-14 12:00:00

LEQEMBIÂ Real-World LEADER Study Presented at AAICÂ 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable a

gurufocus.com - 2026-07-14 12:00:00

LEQEMBIÂ Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented

gurufocus.com - 2026-07-12 12:00:00

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQÂ) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

gurufocus.com - 2026-06-29 04:00:00

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positi

gurufocus.com - 2026-06-26 08:00:00

FORT LAUDERDALE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- AD Mortgage , a leading wholesale lender in the United States, today released findings from its latest broker survey,  Non-QM Fuels Mortgage Industry in 2026  revealing strong momentum for Non-QM lending across the mortgage industry.

globenewswire.com - 2026-06-23 12:30:00

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW.

globenewswire.com - 2026-06-18 12:27:00

VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical results for its novel small molecule, DB-006. The compound demonstrated high efficacy in treating atopic dermatitis (AD), significantly reducing key disease drivers, including pruritus (itch), epithelial thickening, inflammation, and immunoglobulin E (IgE) levels.

globenewswire.com - 2026-06-18 10:00:00

BRONX, N.Y.--(BUSINESS WIRE)-- #Alzheimers--Oligomerix, Inc., a privately held clinical stage company pioneering the development of oral, small molecule therapeutics targeting Alzheimer's (AD) and rare neurodegenerative diseases, announced an NIH Fast Track Phase II award of $1.9 million from the National Institute on Aging of the National Institutes of Health. This grant supports clinical development of OLX-07010, an orally administered investigational drug, targeting pathological tau aggregates that drive.

businesswire.com - 2026-06-17 08:00:00

CAMBRIDGE, Mass. and TAIPEI, June 10, 2026 /PRNewswire/ -- Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim results from its ongoing Phase 2 proof-of-concept study of enrupatinib (EI-1071), a brain-penetrant colony-stimulating factor 1 receptor (CSF-1R) inhibitor designed to modulate neuroinflammation in Alzheimer's disease (AD).

prnewswire.com - 2026-06-10 22:56:00

On June 10, 2026, Array Digital Infrastructure Inc (AD) shares rose 3.1% to a current price of $52.35. The stock has fluctuated within a 52-week range of $44.03

gurufocus.com - 2026-06-10 20:25:00

First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBa

gurufocus.com - 2026-06-10 04:00:00

Board declares special dividend of $11.00 per share CHICAGO, June 1, 2026 /PRNewswire/ -- Array Digital Infrastructure, Inc. (NYSE: AD) (ArraySM) today announced the successful closing of the previously announced agreement with Verizon (NYSE: VZ) to sell a portion of the Company's retained spectrum licenses for total consideration of $1.0 billion.  Additionally, certain spectrum sales to T-Mobile totaling $168M, primarily related to 700MHz and 600MHz, were completed in May.

prnewswire.com - 2026-06-01 16:05:00

As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operat

gurufocus.com - 2026-06-01 09:00:00

Array Digital Infrastructure, Inc. (AD) Shareholder/Analyst Call Prepared Remarks Transcript

seekingalpha.com - 2026-05-19 14:00:51

ARRAY DIGITAL STOCK ALERT: Kaskela Law Firm Announces Stockholder Investigation of Array Digital Infrastructure, Inc. (AD) and Encourages Inves

gurufocus.com - 2026-05-15 10:00:00

PHILADELPHIA, May 15, 2026 /PRNewswire/ -- Stockholder litigation firm Kaskela Law announces that it is investigating Array Digital Infrastructure, Inc. (NYSE: AD) ("Array") on behalf of the company's investors.   Click here for additional information: https://kaskelalaw.com/case/array-digital/ The investigation seeks to determine whether Array and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.

prnewswire.com - 2026-05-15 09:00:00

LOS ANGELES, May 14, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of long-term investors in Array Digital Infrastructure, Inc. (“Array Digital” or “the Company”) (NYSE: AD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Array Digital board breached its fiduciary duties to shareholders, and if the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

globenewswire.com - 2026-05-14 13:29:00

Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease PR Newswire

gurufocus.com - 2026-05-13 21:00:00

The firm is investigating whether the company's representatives violated the securities laws or breached their fiduciary duties, causing investor losses Array's stock price has declined over 21% since August 2025 PHILADELPHIA, May 12, 2026 (GLOBE NEWSWIRE) -- Kaskela Law is investigating Array Digital Infrastructure, Inc. (NYSE: AD) (“Array”) on behalf of the company's long-term shareholders. Click here for additional information: https://kaskelalaw.com/case/array-digital/ Since August 2025, shares of Array's common stock have declined in value from a trading price of over $70.00 per share to a current price of approximately $55.00 per share – a cumulative decline of over 21% in value.

globenewswire.com - 2026-05-12 08:00:00

CHICAGO, May 11, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. [NYSE: TDS] and Array Digital Infrastructure, Inc. [NYSE: AD] announce the following webcasts: Array℠ will hold its Annual Meeting of Shareholders on May 19, 2026, at 8:30 a.m. Central time.

prnewswire.com - 2026-05-11 17:14:00

Array Digital's Q1 revenues jump 93% on tower leasing growth, but earnings and revenues miss estimates as spectrum deals boost profitability.

zacks.com - 2026-05-11 15:16:08

TMUS, AD and LILA are likely to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.

zacks.com - 2026-05-11 12:35:37

Array Digital Infrastructure (AD) came out with quarterly earnings of $2.08 per share, missing the Zacks Consensus Estimate of $5.74 per share. This compares to earnings of $0.21 per share a year ago.

zacks.com - 2026-05-08 09:50:22

Array reaffirms 2026 guidance CHICAGO, May 8, 2026 /PRNewswire/ --  As previously announced, Array will hold a teleconference on May 8, 2026, at 9 :00 a.m. CT . Listen to the call live via the Events & Presentations page of investors.arrayinc.com.

prnewswire.com - 2026-05-08 07:29:00

CHICAGO, May 8, 2026 /PRNewswire/ -- Array Digital Infrastructure, Inc. (NYSE: AD) ("Array" or the "Company") confirmed today that its board of directors (the "Board") has received a non-binding proposal, dated May 7, 2026, from Telephone and Data Systems, Inc. (NYSE: TDS) ("TDS") to acquire all of the outstanding common shares of the Company not currently owned by TDS (the "Proposal"). A copy of the proposal letter from TDS is available as an exhibit to the Current Report on Form 8-K as publicly filed by TDS today with the Securities and Exchange Commission.

prnewswire.com - 2026-05-08 07:15:00

Proposed transaction aims to streamline corporate structure and enhance capital flexibility to support TDS' long-term growth CHICAGO, May 8, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) (the "Company" or "TDS") today announced that it has submitted a proposal to the Board of Directors of Array Digital Infrastructure, Inc. (NYSE: AD) ("Array") to acquire, by way of a merger, all of the outstanding common shares of Array that are not currently owned by TDS in an all-stock transaction. Under the terms of the proposal, each Array Common Share not owned by TDS would be exchanged for 0.86 of a TDS Common Share (the "Exchange Ratio").

prnewswire.com - 2026-05-08 07:00:00

Alaris Equity Partners Income Trust (AD.UN:CA) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 14:11:28

CHICAGO, May 1, 2026 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) and Array Digital Infrastructure, Inc. (NYSE: AD) will webcast their fourth quarter operating results conference call on May 8, 2026, at 9:00 a.m. Central Time.

prnewswire.com - 2026-05-01 08:00:00

Biogen beats Q1 earnings and revenue estimates, fueled by new drug growth, but cuts 2026 EPS outlook to reflect M&A costs.

zacks.com - 2026-04-29 11:21:07

T-Mobile (TMUS) came out with quarterly earnings of $2.7 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $2.58 per share a year ago.

zacks.com - 2026-04-28 18:17:13

On April 23, 2026, Array Digital Infrastructure Inc (AD) shares rose 3.5% to a current price of $48.86. Over the past year, the stock has experienced a 27.1% in

gurufocus.com - 2026-04-23 18:06:00